Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): A randomised, open-label, intergroup study
Andrea Biondi, Martin Schrappe, Paola De Lorenzo, Anders Castor, Giovanna Lucchini, Virginie Gandemer, Rob Pieters, Jan Stary, Gabriele Escherich, Myriam Campbell, Chi Kong Li, Ajay Vora, Maurizio Aricò, Silja Röttgers, Vaskar Saha, Maria Grazia Valsecchi
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): A randomised, open-label, intergroup study'. Together they form a unique fingerprint.